Medsafe Logo
Hide menus
Show menus

Consultations

Published: 7 May 2010

Outcome of the Consultation on the Proposal to Widen Prescriber Access to Clozapine

7 May 2010

Executive summary

A total of 37 submissions were received regarding the consultation on the proposal to widen prescriber access to clozapine:

As a result of the consultation Medsafe will revise the prescribing conditions for clozapine to:

  1. The medicine may only be prescribed by:
    • Registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified by the Medical Council of New Zealand as competent in the scope of practice of psychiatry.
    • Medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of the persons referred to above.
    • Medical officers of special scale who:
      • work solely in the field of psychiatry
      • are in the employment of a District Health Board
      • are under the supervision of persons who are registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified by the Medical Council of New Zealand as competent in the scope of practice of psychiatry.
    • Registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are registered with the Medical Council of New Zealand within the vocational scope of practice of general practice. The general practitioner must be continuing the prescribing of clozapine for a specific patient who is considered stable in collaboration, or following consultation, with a Community Mental Health Team.
  2. Persons prescribing the medicine must comply with appropriate local treatment guidelines.

Further detail on the outcome of the consultation is available in the following report on the analysis of submissions.

Submissions

A total of 34 submissions were received by the deadline of Friday 26 March 2010. Three submissions were received after the deadline but were taken into account in the analysis. The submitters included general practitioners, representatives from the medical profession, the organisation representing general practitioners in New Zealand, representatives of community mental health services, representatives and groups within the field of psychiatry, pharmacists and their representative organisations in New Zealand.

Overall, eighteen (49%) of the submitters supported the proposed prescribing conditions. Fifteen (40%) of the submitters supported the proposed prescribing conditions in principle and recommended further work before the proposal was taken forward. Four (11%) of the submitters opposed the proposal.

Analysis of the submissions received

The most common themes from the submitters who supported the proposed prescribing conditions were:

The most common themes from the submitters who supported the proposed prescribing conditions in principle were:

The most common themes from the submitters who opposed the proposed prescribing conditions in principle were:

Conclusion and Recommendations

Medsafe will progress the proposal to revise the prescribing conditions for clozapine.

The following condition in the proposal:

Will be revised to:

 

0 1 2 4 5 6 7 9 [ /